Trial Profile
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2011
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Granisetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 21 Dec 2011 New trial record